G-protein coupled receptor oligomerization in neuroendocrine pathways
暂无分享,去创建一个
[1] K. Blumer,et al. G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.
[2] A. Surprenant,et al. Dopamine actions on calcium currents, potassium currents and hormone release in rat melanotrophs. , 1991, The Journal of physiology.
[3] Cristina Limatola,et al. Ligand-independent CXCR2 Dimerization* , 2003, Journal of Biological Chemistry.
[4] Lei Shi,et al. The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer* , 2003, The Journal of Biological Chemistry.
[5] L. Potter,et al. Evidence of paired M2 muscarinic receptors. , 1991, Molecular pharmacology.
[6] M. Caron,et al. Phosphorylation and Palmitoylation of the Human D2L Dopamine Receptor in Sf9 Cells , 1994, Journal of neurochemistry.
[7] Susan R. George,et al. G-Protein-coupled receptor oligomerization and its potential for drug discovery , 2002, Nature Reviews Drug Discovery.
[8] Alan Wise,et al. Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.
[9] Andrea Kóbor,et al. Homodimerization of Neuropeptide Y Receptors Investigated by Fluorescence Resonance Energy Transfer in Living Cells* , 2003, The Journal of Biological Chemistry.
[10] H. Akil,et al. Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. , 2000, Molecular pharmacology.
[11] M. Gershengorn,et al. Rat TRH receptor type 2 exhibits higher basal signaling activity than TRH receptor type 1. , 1999, Endocrinology.
[12] T. Gudermann,et al. Structural Implication for Receptor Oligomerization from Functional Reconstitution Studies of Mutant V2 Vasopressin Receptors* , 2000, The Journal of Biological Chemistry.
[13] R. Ahn,et al. Inhibitory activity of alternative splice variants of the bullfrog GnRH receptor-3 on wild-type receptor signaling. , 2001, Endocrinology.
[14] L. Devi,et al. G-protein-coupled receptor dimerization: modulation of receptor function. , 2001, Pharmacology & therapeutics.
[15] Luigi F Agnati,et al. Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons , 2003, Pharmacological Reviews.
[16] L. Limbird,et al. Localization of G-protein-coupled receptors in health and disease. , 2000, Trends in pharmacological sciences.
[17] J. Wess,et al. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[18] B. O'dowd,et al. TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1. , 2000, Molecular endocrinology.
[19] H. Lother,et al. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.
[20] G. Demontis,et al. G protein-linked receptors: pharmacological evidence for the formation of heterodimers. , 1999, The Journal of pharmacology and experimental therapeutics.
[21] Jayaram Chandrashekar,et al. An amino-acid taste receptor , 2002, Nature.
[22] Michel Bouvier,et al. A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.
[23] Michele Zoli,et al. Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors* , 2002, The Journal of Biological Chemistry.
[24] B. Kieffer. Opioids: first lessons from knockout mice. , 1999, Trends in pharmacological sciences.
[25] Manuela Pfeiffer,et al. Heterodimerization of Somatostatin and Opioid Receptors Cross-modulates Phosphorylation, Internalization, and Desensitization* , 2002, The Journal of Biological Chemistry.
[26] Adam J Pawson,et al. A novel mammalian receptor for the evolutionarily conserved type II GnRH , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] E. Brown,et al. Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Nakanishi,et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.
[29] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[30] M. Millan,et al. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626. , 2000, The Journal of pharmacology and experimental therapeutics.
[31] C. Martínez-A,et al. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. C. Stoof,et al. Biochemical and physiological studies of the beta-adrenoceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review. , 1982, Neuroendocrinology.
[33] Kendall J Blumer,et al. The Extracellular N-terminal Domain and Transmembrane Domains 1 and 2 Mediate Oligomerization of a Yeast G Protein-coupled Receptor* , 2002, The Journal of Biological Chemistry.
[34] B. O'dowd,et al. Serotonin 5‐HT1B and 5‐HT1D receptors form homodimers when expressed alone and heterodimers when co‐expressed , 1999, FEBS letters.
[35] B. Barisas,et al. Luteinizing Hormone Receptors Are Self-Associated in the Plasma Membrane* *This work was supported by NIH Grants HD-23236 and HD-01067 (to D.A.R.). , 2000, Endocrinology.
[36] E. Lakatta,et al. 'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart. , 1997, Circulation.
[37] Michel Bouvier,et al. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.
[38] U. Kumar,et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.
[39] C. Martínez-A,et al. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] H Weinstein,et al. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. , 1997, Endocrine reviews.
[41] Y. Patel. Somatostatin and Its Receptor Family , 1999, Frontiers in Neuroendocrinology.
[42] B. Mouillac,et al. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. , 2003, Molecular endocrinology.
[43] L. W. Duck,et al. A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates. , 2001, Biochemical and biophysical research communications.
[44] Julie Perroy,et al. A Single Subunit (GB2) Is Required for G-protein Activation by the Heterodimeric GABAB Receptor* , 2002, The Journal of Biological Chemistry.
[45] J. Wess,et al. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co‐expressed receptor polypeptide. , 1996, The EMBO journal.
[46] C. Johnson,et al. A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[47] L. Devi,et al. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[48] G. Pearlson,et al. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. , 1995, Archives of general psychiatry.
[49] Pierre Corvol,et al. Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling , 1996, The Journal of Biological Chemistry.
[50] Kendall J Blumer,et al. C5a Receptor Oligomerization , 2003, Journal of Biological Chemistry.
[51] C. Halldin,et al. Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man , 1995, Synapse.
[52] T. Fenton,et al. Oligomerization of G-protein-coupled Receptors Shown by Selective Co-immunoprecipitation* , 2002, The Journal of Biological Chemistry.
[53] E I Canela,et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[54] F. Piva,et al. Inhibition of luteinizing hormone-releasing hormone secretion by delta-opioid agonists in GT1-1 neuronal cells. , 1995, Endocrinology.
[55] B. Barisas,et al. Binding of agonist but not antagonist leads to fluorescence resonance energy transfer between intrinsically fluorescent gonadotropin-releasing hormone receptors. , 2001, Molecular endocrinology.
[56] A. Hanyaloglu,et al. Applications of novel resonance energy transfer techniques to study dynamic hormone receptor interactions in living cells , 2002, Trends in Endocrinology & Metabolism.
[57] F. Ciruela,et al. Characterization of the Dimerization of Metabotropic Glutamate Receptors Using an N‐Terminal Truncation of mGluR1α , 1999, Journal of neurochemistry.
[58] M. Caron,et al. Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. , 1988, Science.
[59] S. Nakanishi,et al. Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. , 2000, The Journal of biological chemistry.
[60] Horst Vogel,et al. Oligomerization of the α1a- and α1b-Adrenergic Receptor Subtypes , 2003, Journal of Biological Chemistry.
[61] Jamie Fong,et al. Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization , 2002, Cell.
[62] Y. Wang,et al. A study of protein-protein interactions in living cells using luminescence resonance energy transfer (LRET) from Renilla luciferase to Aequorea GFP , 2001, Molecular and General Genetics MGG.
[63] Yoshinori Shichida,et al. Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[64] T. Kohout,et al. Homo- and Hetero-oligomerization of Thyrotropin-releasing Hormone (TRH) Receptor Subtypes , 2002, The Journal of Biological Chemistry.
[65] A. Cornea,et al. Gonadotropin-releasing Hormone Receptor Microaggregation , 2001, The Journal of Biological Chemistry.
[66] D. A. Brown,et al. GABAB2 Is Essential for G-Protein Coupling of the GABAB Receptor Heterodimer , 2001, The Journal of Neuroscience.
[67] S. Schulz,et al. Homo- and Heterodimerization of Somatostatin Receptor Subtypes , 2001, The Journal of Biological Chemistry.
[68] F. Petraglia,et al. Opioid control of luteinizing hormone secretion in humans. , 1989, Journal of steroid biochemistry.
[69] R. Crystal,et al. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. , 2002, Human gene therapy.
[70] J. Venter,et al. Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation. , 1983, Molecular pharmacology.
[71] Lakshmi A. Devi,et al. Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.
[72] B. O'dowd,et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.
[73] M. Memo,et al. Dopaminergic Inhibition of Prolactin Release and Calcium Influx Induced by Neurotensin in Anterior Pituitary Is Independent of Cyclic AMP System , 1986, Journal of neurochemistry.
[74] H. Jinnah,et al. Regulation of gonadotropin release, GnRH receptors, and gonadotrope responsiveness: A role for GnRH receptor microaggregation , 1985, Journal of cellular biochemistry.
[75] S. Jiang,et al. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. , 1997, Cancer research.
[76] R. Lefkowitz,et al. Negative cooperativity among beta-adrenergic receptors in frog erythrocyte membranes. , 1976, The Journal of biological chemistry.
[77] C. Gerfen,et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[78] Y. Jan,et al. A Trafficking Checkpoint Controls GABAB Receptor Heterodimerization , 2000, Neuron.
[79] P. Conn,et al. Biphasic regulation of the gonadotropin-releasing hormone receptor by receptor microaggregation and intracellular Ca2+ levels. , 1984, Molecular pharmacology.
[80] P. Fossier,et al. Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.
[81] K. Fuxe,et al. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[82] S. Rees,et al. Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.
[83] H. Lother,et al. Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness , 2001, Nature Medicine.
[84] R. Bílek. TRH-like peptides in prostate gland and other tissues. , 2000, Physiological research.
[85] S. R. Nash,et al. Dopamine receptors: from structure to function. , 1998, Physiological reviews.
[86] L. Devi,et al. Oligomerization of opioid receptors. , 2002, Methods.
[87] T. Wong,et al. Cross-talk Between Cardiacκ-Opioid andβ-Adrenergic Receptors in Developing Hypertensive Rats , 1999 .
[88] W. A. Smith,et al. Microaggregation of the gonadotropin-releasing hormone-receptor: relation to gonadotrope desensitization. , 1984, Endocrinology.
[89] R. Millar. GnRH II and type II GnRH receptors , 2003, Trends in Endocrinology & Metabolism.
[90] Gilles Labesse,et al. No Ligand Binding in the GB2 Subunit of the GABABReceptor Is Required for Activation and Allosteric Interaction between the Subunits , 2002, The Journal of Neuroscience.
[91] Mario Mellado,et al. Chemokine receptor homo‐ or heterodimerization activates distinct signaling pathways , 2001, The EMBO journal.
[92] U. Kumar,et al. Expression of the Five Somatostatin Receptor (SSTR1-5) Subtypes in Rat Pituitary Somatotrophes: Quantitative Analysis by Double-Label Immunofluorescence Confocal Microscopy. , 1997, Endocrinology.
[93] A. Horita,et al. An update on the CNS actions of TRH and its analogs. , 1998, Life sciences.
[94] H. Lother,et al. The Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist* , 2001, The Journal of Biological Chemistry.
[95] S. Nakanishi,et al. Amino Acid Mutagenesis of the Ligand Binding Site and the Dimer Interface of the Metabotropic Glutamate Receptor 1 , 2003, The Journal of Biological Chemistry.
[96] Kuan-Teh Jeang,et al. Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32* , 1997, The Journal of Biological Chemistry.
[97] M. Gershengorn,et al. Thyrotropin-releasing hormone receptors -- similarities and differences. , 2003, Journal of molecular endocrinology.
[98] H. Nakata,et al. Agonist‐promoted heteromeric oligomerization between adenosine A1 and P2Y1 receptors in living cells , 2002, FEBS letters.
[99] A. Norman,et al. Heptahelical receptor superfamily , 2003 .
[100] S. Schulz,et al. Selective targeting of somatostatin receptor 3 to neuronal cilia , 1999, Neuroscience.
[101] H. Iwaasa,et al. Cloning and characterization of a new subtype of thyrotropin-releasing hormone receptors. , 1998, Biochemical and biophysical research communications.
[102] G. Milligan,et al. Oligomerisation of G-protein-coupled receptors. , 2001, Journal of cell science.
[103] E. Hazum,et al. Gonadotropin releasing hormone activation is mediated by dimerization of occupied receptors. , 1985, Biochemical and biophysical research communications.
[104] S. Wilt,et al. Heterodimerization of Calcium Sensing Receptors with Metabotropic Glutamate Receptors in Neurons* , 2001, The Journal of Biological Chemistry.
[105] K. Davis,et al. Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[106] E. Brown,et al. The Extracellular Calcium-sensing Receptor Dimerizes through Multiple Types of Intermolecular Interactions* , 2001, The Journal of Biological Chemistry.
[107] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[108] J. Wess,et al. Reconstitution of functional muscarinic receptors by co‐expression of amino‐ and carboxyl‐terminal receptor fragments , 1993, FEBS letters.
[109] Krzysztof Palczewski,et al. Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.
[110] E. Lakatta,et al. β1/β2-Adrenergic Receptor Heterodimerization Regulates β2-Adrenergic Receptor Internalization and ERK Signaling Efficacy* , 2002, The Journal of Biological Chemistry.
[111] K Payza,et al. Cloning and Characterization of a cDNA Encoding a Novel Subtype of Rat Thyrotropin-releasing Hormone Receptor* , 1998, The Journal of Biological Chemistry.
[112] T. Gudermann,et al. Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. , 1997, Molecular endocrinology.
[113] Lakshmi A. Devi,et al. G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.
[114] U. Kumar,et al. Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.
[115] L. Miller,et al. Agonist-dependent Dissociation of Oligomeric Complexes of G Protein-coupled Cholecystokinin Receptors Demonstrated in Living Cells Using Bioluminescence Resonance Energy Transfer* , 2001, The Journal of Biological Chemistry.
[116] J Engel,et al. Heterodimerization of a functional GABAB receptor is mediated by parallel coiled-coil alpha-helices. , 1999, Biochemistry.
[117] A. Norman,et al. Encyclopedia of hormones , 2003 .
[118] P. Seeman,et al. Dopamine D2 receptor dimers in human and rat brain , 1998, FEBS letters.
[119] A. Lau,et al. Heterodimerization of α2A- and β1-Adrenergic Receptors* , 2003, The Journal of Biological Chemistry.
[120] Paul D. Scott,et al. Dimerization of G-protein-coupled receptors. , 2001 .
[121] J. Janovick,et al. Gonadotropin releasing hormone agonist provokes homologous receptor microaggregation: an early event in seven-transmembrane receptor mediated signaling. , 1996, Endocrinology.
[122] Ramesh C. Patel,et al. Photobleaching fluorescence resonance energy transfer reveals ligand-induced oligomer formation of human somatostatin receptor subtypes. , 2002, Methods.
[123] Roger Y Tsien,et al. Recent advances in technology for measuring and manipulating cell signals , 2000, Current Opinion in Neurobiology.
[124] M. Entman,et al. Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting. , 1985, The Journal of biological chemistry.
[125] M. Gershengorn,et al. Regulator of G Protein Signaling 4 Suppresses Basal and Thyrotropin Releasing-Hormone (TRH)-Stimulated Signaling by Two Mouse TRH Receptors, TRH-R1 and TRH-R2. , 2001, Endocrinology.
[126] R. Shigemoto,et al. GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.
[127] J. Wess,et al. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. , 1997, The Journal of clinical investigation.
[128] A. Arai,et al. The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor clustering. , 2001, Molecular pharmacology.
[129] L. Prézeau,et al. C-Terminal Interaction Is Essential for Surface Trafficking But Not for Heteromeric Assembly of GABAB Receptors , 2001, The Journal of Neuroscience.
[130] F. Ciruela,et al. Metabotropic Glutamate 1α and Adenosine A1 Receptors Assemble into Functionally Interacting Complexes* , 2001, The Journal of Biological Chemistry.
[131] Michel Bouvier,et al. Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.
[132] Graeme Milligan,et al. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. , 2002, The Biochemical journal.
[133] A. Engel,et al. Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.
[134] D. Wong,et al. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428 , 1993, Synapse.
[135] J. Stewart,et al. Conversion of a gonadotropin-releasing hormone antagonist to an agonist , 1982, Nature.
[136] R. Latif,et al. Ligand-dependent Inhibition of Oligomerization at the Human Thyrotropin Receptor* , 2002, The Journal of Biological Chemistry.
[137] D C Teller,et al. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.
[138] Alan A. Wilson,et al. Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone , 1993, Psychiatry Research.
[139] P. Seeman,et al. A Transmembrane Domain-derived Peptide Inhibits D1 Dopamine Receptor Function without Affecting Receptor Oligomerization* , 1998, The Journal of Biological Chemistry.
[140] Adam J Pawson,et al. A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12. , 2003, Endocrinology.
[141] M. Bouvier,et al. Functional rescue of a constitutively desensitized beta2AR through receptor dimerization. , 1998, The Biochemical journal.
[142] Lakshmi A Devi,et al. Opioids and Their Complicated Receptor Complexes , 2000, Neuropsychopharmacology.
[143] S. Ferré,et al. Adenosine as a volume transmission signal. A feedback detector of neuronal activation. , 2000, Progress in brain research.
[144] K. Ray,et al. Cys-140 Is Critical for Metabotropic Glutamate Receptor-1 Dimerization* , 2000, The Journal of Biological Chemistry.
[145] Kenneth A. Jones,et al. GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2 , 1998, Nature.
[146] S. Schulz,et al. Immunocytochemical localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia , 1998, The European journal of neuroscience.
[147] C. Bergson,et al. On the origin of mRNA encoding the truncated dopamine D3-type receptor D3nf and detection of D3nf-like immunoreactivity in human brain. , 1994, The Journal of biological chemistry.
[148] L. Prézeau,et al. Mapping the Agonist-binding Site of GABAB Type 1 Subunit Sheds Light on the Activation Process of GABABReceptors* , 2000, The Journal of Biological Chemistry.
[149] Y. Kuroda,et al. Hetero‐oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains , 2002, FEBS letters.
[150] Enrico Gratton,et al. Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[151] J. Morrison,et al. Expression of Dopamine D3 Receptor Dimers and Tetramers in Brain and in Transfected Cells* , 1997, The Journal of Biological Chemistry.
[152] Lakshmi A. Devi,et al. G protein coupled receptor dimerization: implications in modulating receptor function , 2001, Journal of Molecular Medicine.
[153] H. Lother,et al. Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor Dimerization* , 1999, The Journal of Biological Chemistry.
[154] S. Stone-Elander,et al. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. , 1990, Archives of general psychiatry.
[155] Michel Bouvier,et al. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000 .
[156] Chang-Cheng Zhu,et al. Dimerization and Phosphorylation of Thyrotropin-releasing Hormone Receptors Are Modulated by Agonist Stimulation* , 2002, The Journal of Biological Chemistry.
[157] J. Bockaert,et al. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. , 1983, Molecular pharmacology.
[158] J. Venter,et al. Molecular size of the human platelet alpha 2-adrenergic receptor as determined by radiation inactivation. , 1983, Biochemical and biophysical research communications.
[159] G. Corsini,et al. Functional Role of the Third Cytoplasmic Loop in Muscarinic Receptor Dimerization* , 1996, The Journal of Biological Chemistry.
[160] Michel Bouvier,et al. Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210 , 2002, The Journal of Biological Chemistry.
[161] J. Wess,et al. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. , 1998, Biochemistry.
[162] T. Yaksh. New horizons in our understanding of the spinal physiology and pharmacology of pain processing. , 1993, Seminars in oncology.
[163] Jie Liu,et al. Plasma Membrane Localization and Functional Rescue of Truncated Forms of a G Protein-coupled Receptor (*) , 1995, The Journal of Biological Chemistry.
[164] R Levenson,et al. The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. , 2000, Molecular pharmacology.
[165] P. Seeman,et al. Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells. , 1997, Endocrinology.
[166] A. Hanyaloglu,et al. Constitutive and Agonist-dependent Homo-oligomerization of the Thyrotropin-releasing Hormone Receptor , 2001, The Journal of Biological Chemistry.
[167] S. Nakagawa,et al. The metabolic rate and vulnerability of dopaminergic neurons, and adenosine dynamics in the cerebral cortex, nucleus accumbens, caudate nucleus, and putamen of the common marmoset , 2000, Journal of Neurology.
[168] P. Seeman,et al. Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.
[169] Hans Bräuner-Osborne,et al. Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET). , 2002, European journal of biochemistry.
[170] C. Romano,et al. Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer* , 1996, The Journal of Biological Chemistry.
[171] N. Ben-Jonathan. Dopamine: a prolactin-inhibiting hormone. , 1985, Endocrine reviews.
[172] E. Brown,et al. Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 Cells* , 1998, The Journal of Biological Chemistry.
[173] H. Nakata,et al. Heteromeric association creates a P2Y-like adenosine receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[174] Gregory J Babcock,et al. Ligand-independent Dimerization of CXCR4, a Principal HIV-1 Coreceptor* , 2003, The Journal of Biological Chemistry.
[175] Christer Halldin,et al. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone , 1995, Psychiatry Research: Neuroimaging.
[176] L. Miller,et al. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. , 2002, Cancer research.
[177] J. Wess,et al. Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.
[178] B. O'dowd,et al. The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerization. , 2000, Brain research. Molecular brain research.
[179] P. Cuatrecasas,et al. Increased biological activity of dimers of oxymorphone and enkephalin: possible role of receptor crosslinking. , 1982, Biochemical and biophysical research communications.
[180] H. Nakata,et al. Oligomerization of adenosine A2A and dopamine D2 receptors in living cells. , 2003, Biochemical and biophysical research communications.
[181] P. Sokoloff,et al. D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties* , 2001, The Journal of Biological Chemistry.
[182] R. Russell,et al. The C-Terminal Domains of the GABAB Receptor Subunits Mediate Intracellular Trafficking But Are Not Required for Receptor Signaling , 2001, The Journal of Neuroscience.
[183] Jean-François Mercier,et al. Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer* , 2002, The Journal of Biological Chemistry.
[184] K. Roche,et al. Homer 1b Regulates the Trafficking of Group I Metabotropic Glutamate Receptors* , 1999, The Journal of Biological Chemistry.
[185] C Higgs,et al. Domain swapping in G-protein coupled receptor dimers. , 1998, Protein engineering.
[186] Christopher A Reynolds,et al. Dimerization and Domain Swapping in G-Protein-Coupled Receptors: A Computational Study , 2000, Neuropsychopharmacology.
[187] P. Pauwels,et al. Agonist‐independent and ‐dependent oligomerization of dopamine D2 receptors by fusion to fluorescent proteins , 2001, FEBS letters.